CELC
Price
$10.35
Change
+$0.12 (+1.17%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
384.29M
8 days until earnings call
VXRT
Price
$0.46
Change
-$0.00 (-0.00%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
103.96M
Earnings call today
Ad is loading...

CELC vs VXRT

Header iconCELC vs VXRT Comparison
Open Charts CELC vs VXRTBanner chart's image
Celcuity
Price$10.35
Change+$0.12 (+1.17%)
Volume$2.85K
Capitalization384.29M
Vaxart
Price$0.46
Change-$0.00 (-0.00%)
Volume$6.71K
Capitalization103.96M
CELC vs VXRT Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CELC vs. VXRT commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and VXRT is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (CELC: $10.23 vs. VXRT: $0.46)
Brand notoriety: CELC and VXRT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 65% vs. VXRT: 68%
Market capitalization -- CELC: $381.69M vs. VXRT: $104.64M
CELC [@Biotechnology] is valued at $381.69M. VXRT’s [@Biotechnology] market capitalization is $104.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileVXRT’s FA Score has 1 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • VXRT’s FA Score: 1 green, 4 red.
According to our system of comparison, both CELC and VXRT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while VXRT’s TA Score has 3 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 5 bearish.
  • VXRT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CELC is a better buy in the short-term than VXRT.

Price Growth

CELC (@Biotechnology) experienced а +14.94% price change this week, while VXRT (@Biotechnology) price change was -2.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

CELC is expected to report earnings on May 07, 2025.

VXRT is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($384M) has a higher market cap than VXRT($104M). CELC YTD gains are higher at: -21.849 vs. VXRT (-30.524). VXRT has higher annual earnings (EBITDA): -60.22M vs. CELC (-85.45M). CELC has more cash in the bank: 264M vs. VXRT (58.7M). VXRT has less debt than CELC: VXRT (18.2M) vs CELC (97.2M). VXRT has higher revenues than CELC: VXRT (20.1M) vs CELC (0).
CELCVXRTCELC / VXRT
Capitalization384M104M369%
EBITDA-85.45M-60.22M142%
Gain YTD-21.849-30.52472%
P/E RatioN/AN/A-
Revenue020.1M-
Total Cash264M58.7M450%
Total Debt97.2M18.2M534%
FUNDAMENTALS RATINGS
CELC vs VXRT: Fundamental Ratings
CELC
VXRT
OUTLOOK RATING
1..100
7954
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9191
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VXRT's Valuation (30) in the Biotechnology industry is in the same range as CELC (40) in the Miscellaneous Commercial Services industry. This means that VXRT’s stock grew similarly to CELC’s over the last 12 months.

VXRT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that VXRT’s stock grew similarly to CELC’s over the last 12 months.

VXRT's SMR Rating (98) in the Biotechnology industry is in the same range as CELC (98) in the Miscellaneous Commercial Services industry. This means that VXRT’s stock grew similarly to CELC’s over the last 12 months.

VXRT's Price Growth Rating (91) in the Biotechnology industry is in the same range as CELC (91) in the Miscellaneous Commercial Services industry. This means that VXRT’s stock grew similarly to CELC’s over the last 12 months.

VXRT's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CELC (100) in the Miscellaneous Commercial Services industry. This means that VXRT’s stock grew similarly to CELC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CELCVXRT
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VXRT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with CLDX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-3.85%
CLDX - CELC
42%
Loosely correlated
-5.37%
ABOS - CELC
42%
Loosely correlated
-4.00%
CRNX - CELC
42%
Loosely correlated
+1.41%
PRME - CELC
40%
Loosely correlated
-13.33%
MLYS - CELC
40%
Loosely correlated
+42.21%
More

VXRT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VXRT has been loosely correlated with PRME. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if VXRT jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VXRT
1D Price
Change %
VXRT100%
-2.09%
PRME - VXRT
36%
Loosely correlated
-13.33%
CVAC - VXRT
36%
Loosely correlated
-3.95%
VOR - VXRT
36%
Loosely correlated
-9.99%
CRSP - VXRT
36%
Loosely correlated
-4.81%
CELC - VXRT
35%
Loosely correlated
-3.85%
More